CA$
0. 05
-0
-10%
CA$
2.4M Market Cap
- P/E Ratio
- Div Yield
38,368 Volume
- Eps
CA$ 0.05
Previous Close Want to track DMED and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
DMED closed today lower at CA$0.05, a decrease of -10% from yesterday's close, completing a monthly decrease of -10% or CA$0. Over the past 12 months, DMED stock lost -30.7692%.
DMED is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 4 different exchanges and in various currencies, with the primary listing on CNSX (CAD).
DiagnaMed Holdings Corp. (DMED) FAQ
What is the stock price today?
The current price is CA$0.05.
On which exchange is it traded?
DiagnaMed Holdings Corp. is listed on CNSX.
What is its stock symbol?
The ticker symbol is DMED.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 2.4M.
Has DiagnaMed Holdings Corp. ever had a stock split?
No, there has never been a stock split.
DiagnaMed Holdings Corp. Profile
| Insurance Industry | Financials Sector | Mr. Fabio Chianelli CEO | CNSX Exchange | CA25245D1033 ISIN |
| Canada Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Diagnamed Holdings Corp. is at the forefront of revolutionizing mental health and neurological disorders treatment through its digital health artificial intelligence initiatives. Based out of Toronto, Canada, the company is dedicated to developing and commercializing state-of-the-art digital therapeutics. Leveraging the power of AI, Diagnamed targets the enhancement of patient care in the realms of mental health and neurology, addressing a critical gap in current healthcare solutions.
Products and Services
The company’s innovative portfolio includes:
- CERVAI: A cutting-edge brain health AI platform designed to advance the management and treatment of neurological disorders. CERVAI employs artificial intelligence to provide insights and therapeutic options tailored to the unique neurological profiles of individuals, fostering better outcomes in brain health.
- Health GenAI: This suite of generative AI solutions for the healthcare market integrates OpenAI's ChatGPT. It is crafted to transform the quality and accessibility of healthcare services through advanced AI tools, ensuring healthcare providers and patients have access to the latest in medical AI technology.
- Dr. GENAI: A personal AI medical chatbot, Dr. GENAI is engineered to offer fast and personalized medical information. By understanding a person's unique medical condition, it provides tailored medical advice, aiming to bridge the gap between patients and immediate healthcare guidance.
- Brain Age: An innovative machine-learning solution based on electroencephalogram (EEG) technology, Brain Age is developed to determine an individual's brain age. This tool is intended for both clinical and home use, providing users and healthcare providers with valuable insights into brain health and aging.
Contact Information
Address: 82 Richmond Street East
Phone: 416 800 2684
Website: https://www.diagnamed.com
